Published in BMJ Open on August 26, 2015
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med (2011) 11.09
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol (2012) 6.05
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med (2011) 4.69
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer (2009) 4.28
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer (2004) 4.04
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet (2011) 3.86
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis (2012) 3.19
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer (2009) 3.15
Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med (1987) 2.74
Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis (2012) 2.51
Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol (1995) 2.33
Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer (2008) 2.03
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. J Low Genit Tract Dis (2015) 1.73
One virus, one lesion--individual components of CIN lesions contain a specific HPV type. J Pathol (2012) 1.67
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med (2013) 1.64
Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: an Australian perspective. Acta Cytol (2011) 1.64
Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol (2004) 1.62
Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.60
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. Lancet Oncol (2013) 1.47
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer (2014) 1.40
Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer (2010) 1.38
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med (2012) 1.38
Cancers attributable to human papillomavirus infection. Sex Health (2010) 1.33
Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer (2006) 1.33
Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum (2009) 1.32
The epidemiology of anal cancer. Sex Health (2012) 1.30
Trends in anal cancer in Australia, 1982-2005. Vaccine (2011) 1.24
Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS (2009) 1.22
The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology: results from a global study. Am J Surg Pathol (2013) 1.21
Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol (2010) 1.19
Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J Virol Methods (2007) 1.19
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection. Int J Cancer (2011) 1.12
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies. J Urol (2014) 1.10
Human papillomavirus genotypes in anal intraepithelial neoplasia and anal carcinoma as detected in tissue biopsies. Mod Pathol (2009) 1.06
CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease. Int J Cancer (2013) 1.06
Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with "low-risk" HPV genotypes 6 and 11. Int J Cancer (2013) 1.05
Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation. PLoS One (2011) 1.04
Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis (2013) 1.02
Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions. Int J Cancer (2012) 1.00
Squamous anal cancer: patient characteristics and HPV type distribution. Cancer Epidemiol (2013) 0.99
The increasing incidence of anal cancer: can it be explained by trends in risk groups? Neth J Med (2013) 0.97
P16/CDKN2A and Ki-67 enhance the detection of anal intraepithelial neoplasia and condyloma and correlate with human papillomavirus detection by polymerase chain reaction. Am J Surg Pathol (2010) 0.96
Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immune Defic Syndr (2008) 0.96
Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men. J Acquir Immune Defic Syndr (2005) 0.95
Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis (2012) 0.95
DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma. Clin Cancer Res (2005) 0.90
The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study. BMC Public Health (2013) 0.89
The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health (2012) 0.89
Epidemiology, natural history and risk factors for anal intraepithelial neoplasia. Sex Health (2012) 0.88
Interventions for anal canal intraepithelial neoplasia. Cochrane Database Syst Rev (2012) 0.82
One lesion, one virus: individual components of high-grade anal intraepithelial neoplasia in HIV-positive men contain a single HPV type. J Infect Dis (2014) 0.81
Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers. Int J Cancer (2014) 0.81
Five-year cumulative incidence of invasive anal cancer among HIV-infected patients according to baseline anal cytology results: an inception cohort analysis. HIV Med (2014) 0.81
Australia leads way on HPV vaccination in boys. Lancet Infect Dis (2012) 0.79
HPV-QUEST: A highly customized system for automated HPV sequence analysis capable of processing Next Generation sequencing data set. Bioinformation (2012) 0.77
The epidemiology of anal human papillomavirus infection among women and men having sex with women. Sex Health (2012) 0.76
The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study. BMC Public Health (2013) 0.89
Vaccine-preventable anal human papillomavirus in Australian gay and bisexual men. Papillomavirus Res (2017) 0.75
Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men. Papillomavirus Res (2016) 0.75
The performance of anal cytology as a screening test for anal HSILs in homosexual men. Cancer Cytopathol (2016) 0.75